Related Experiment Videos
Selecting nucleic acids for biosensor applications.
Manjula Rajendran1, Andrew D Ellington
1Department of Chemistry and Biochemistry, University of Texas at Austin, Austin, TX 78712, USA.
Combinatorial Chemistry & High Throughput Screening
|June 8, 2002
Summary
Nucleic acid aptamers and ribozymes can be engineered into biosensors for molecule detection. These aptazymes offer a versatile platform for detecting a wide range of biological targets, potentially revolutionizing diagnostics.
Area of Science:
- Biotechnology
- Molecular Biology
- Biosensor Technology
Background:
- Nucleic acids, through their secondary structures, can be engineered into functional molecules like aptamers (binding) and ribozymes (catalysis).
- Existing nucleic acid biosensors often rely on labeling or specific ligand-induced conformational changes for detection.
Purpose of the Study:
- To explore the potential of engineering nucleic acid-based biosensors (aptazymes) for broad molecular recognition.
- To investigate the development of homogeneous solution-based biosensors and array formats for detecting non-nucleic acid targets.
Main Methods:
- In vitro selection techniques to generate aptamers and ribozymes with specific molecular recognition capabilities.
- Engineering aptamers and ribozymes to exhibit ligand-dependent conformational changes for signaling.
- Development of automated methods for generating aptazymes responsive to diverse biological molecules.
Main Results:
- Successful generation of nucleic acid binding species (aptamers) and catalysts (ribozymes).
- Demonstrated ability to engineer aptamers and ribozymes into biosensors capable of detecting various molecules.
- Development of biosensors that report ligand presence in homogeneous solutions via conformational changes.
Conclusions:
- Nucleic acid engineering offers a powerful strategy for creating versatile biosensors.
- Aptazymes hold promise for detecting a significant portion of an organism's proteome and metabolome using automated methods.
- Nucleic acid biosensor arrays could be developed with similar ease to DNA chips for non-nucleic acid targets.